1.
J Int Assoc Physicians AIDS Care (Chic)
; 8(2): 85-6, 2009.
Article
in English
| MEDLINE
| ID: mdl-19369697
Subject(s)
HIV Envelope Protein gp41/administration & dosage , HIV Infections/drug therapy , HIV-1/drug effects , Peptide Fragments/administration & dosage , Pyrrolidinones/administration & dosage , Quality of Life , Viral Load , Adult , Drug Administration Schedule , Enfuvirtide , Female , HIV Envelope Protein gp41/therapeutic use , HIV Fusion Inhibitors/administration & dosage , HIV Fusion Inhibitors/therapeutic use , HIV Infections/virology , HIV Integrase Inhibitors/administration & dosage , HIV Integrase Inhibitors/therapeutic use , HIV-1/physiology , Humans , Male , Middle Aged , Peptide Fragments/therapeutic use , Pyrrolidinones/therapeutic use , Raltegravir Potassium , Surveys and Questionnaires , Time Factors , Treatment Outcome
2.
Arch Intern Med
; 166(13): 1417, 2006 Jul 10.
Article
in English
| MEDLINE
| ID: mdl-16832008